Skip to main content

Advancing Digital Health Solutions in Ghana with StudyU and StudyMe

· 2 min read

The study, titled "Enhancing Digital N-of-1 Trial: A Comprehensive Exploration of User and Clinician Engagement, Motivations, and Experiences in Ghana Using the StudyMe and StudyU Apps," focuses on exploring how digital tools can be used to design personalized trials.

Clinicians use StudyU to design these trials, capturing valuable data on feasibility and design challenges in low-resource settings like Ghana. We believe this addresses critical gaps in the personalized medicine landscape in Ghana. We seek to suggest refinements, enhancements and functionality of the StudyMe and StudyU applications, improving user experiences across diverse geographical and technological contexts.

Role of StudyU and StudyMe in the project​

StudyU is utilized by clinicians to design trials without implementing them, gathering insights into the trial design process under the constraints typical in Ghana. StudyMe is used by the general public, who design and implement trials, providing real-world feedback on the applicability and effectiveness of these personalized approaches.

Insights and impact​

This study is pivotal in understanding how digital tools like StudyU and StudyMe can be optimized for use in diverse environments, particularly in settings that face significant resource constraints. The insights from this study will guide enhancements to both apps, making them more adaptable and user-friendly for clinicians and patients in developing regions.

Study team​

Supervision: Dr. Stefan Konigorski and spearheaded by Godsway Sackey; Health Intervention Analytics Lab of the Hasso Plattner Institute, University of Potsdam, Germany.

Collaborators: Prof. Frank Baiden and others from the School of Public Health, UHAS, Ghana.

Participants: The study includes 300 individuals from the public across sixteen regions in Ghana and approximately 20 physicians in six regions. The study engages clinicians using the StudyU App to design N-of-1 trials, and participants from the general public who will use the StudyMe App for personal trials.